Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.6700
+0.0300 (1.83%)
NASDAQ · Last Trade: Feb 14th, 1:23 AM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors